Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-06

Clinical Trial Update: Dabigatran Etexilate in Patients With Mechanical Heart Valves [Phase 2]

View source ↗

Summary

Phase 2 trial of dabigatran etexilate in patients with mechanical heart valves was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dabigatran etexilate (Dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Heart Valve Diseases | Phase 2 | Status: TERMINATED | Results posted: 2014-08-06